Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Quality & Risk

    Fault Tree Analysis(FTA)

    In one line
    Top-down deductive analysis tracing how faults can combine to cause an undesired event.
    Definition
    FTA per IEC 61025 uses Boolean logic to model how component-level faults and external events combine to cause a defined top-level hazardous event, supporting both qualitative and quantitative analysis. FTA is a top-down method: it starts from an undesired event, such as overdose delivered, and works down through AND and OR gates to basic causes. It complements bottom-up FMEA by revealing combinations of faults and common-cause failures. In medical devices it is often used for high severity hazards and software-controlled safety functions, and quantitative FTA needs reliable failure rate data.
    Why it matters
    Often paired with FMEA: FTA reasons backward from a harm; FMEA reasons forward from components. FTA is favored for systems with safety-critical software and rare catastrophic failure modes.
    Common pitfalls
    • •Failing to clearly define the top-level event can lead to a convoluted and ineffective fault tree.
    • •Overlooking common cause failures or human error in the fault tree can significantly underestimate risk.
    • •Treating FTA as a standalone activity rather than an iterative part of the product lifecycle reduces its effectiveness.
    • •Applying FTA to systems without well-defined failure modes or clear causal relationships can yield misleading results.
    • •Not adequately validating the fault tree against real-world data or expert opinion can compromise its accuracy and credibility.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.